BCRX
BioCryst Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.96
−1.29%Leverage
- Debt / equity
- -0.90x
- Net debt / equity
- -0.56x
- Debt / assets
- 0.73x
- Debt / EBITDA
- -1.35x
- Net debt / EBITDA
- -0.84x
Liquidity & coverage
- Current ratio
- 2.32x
- Quick ratio
- 2.29x
- Cash ratio
- 1.69x
- Interest coverage
- -4.16x
- EBITDA / interest
- -4.02x
- Working capital
- $275.8M
Cash & dividend
- FCF / debt
- 0.87x
- Cash flow / debt
- 0.88x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026